{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:14:37Z","timestamp":1790723677808,"version":"4.1.0"},"reference-count":88,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Aneurysmal subarachnoid hemorrhage (aSAH) remains a life-threatening cerebrovascular event with high rates of mortality and long-term morbidity. Among its complications, delayed cerebral ischemia (DCI) is a major contributor to poor clinical outcomes. Although cerebral vasospasm has traditionally been considered the primary mechanism underlying DCI, recent studies have revealed the multifactorial nature of this condition. This review aims to provide a comprehensive overview of the pathophysiology, preventive strategies, and current treatment options for DCI following aSAH. Methods: A narrative literature review was conducted using the PubMed database to identify peer-reviewed articles relevant to the prevention and treatment of DCI following aSAH. The search strategy employed the following terms: (\u201cSubarachnoid Hemorrhage\u201d [MeSH]) AND \u201cDelayed Cerebral Ischemia\u201d AND (\u201cPrevention and Control\u201d [Subheading] OR \u201cSecondary Prevention\u201d [MeSH]). This search strategy was designed to capture studies addressing both pharmacological and non-pharmacological preventive measures for DCI. Results: A comprehensive PubMed search identified a total of 113 relevant articles. Among these, 40 publications primarily addressed pharmacological interventions, while 22 focused on neuromonitoring techniques. An additional 20 articles explored the pathophysiological mechanisms underlying DCI, and 15 involved preclinical studies utilizing animal models. The remaining 16 articles encompassed diverse topics, including prophylactic endovascular therapies, newly proposed definitions of DCI, treatment algorithm development, functional outcome analyses, and entries in clinical trial registries. Emerging evidence highlights that vasospasm alone does not account for all cases of DCI. Pharmacological approaches such as nimodipine, clazosentan, and fasudil have shown varying degrees of efficacy. Circulatory management and removal of subarachnoid hematoma via CSF drainage or thrombolytics may reduce DCI risk, although their impact on long-term neurological outcomes remains controversial. Endovascular therapy and adjunctive agents such as cilostazol or anticoagulants have demonstrated potential but require further validation through large-scale trials. Conclusions: Effective DCI prevention and treatment require a multimodal approach targeting diverse pathological mechanisms beyond vasospasm. Improved risk stratification, early detection, and individualized therapy are essential for advancing the management of patients with aSAH.<\/jats:p>","DOI":"10.3390\/jcm14103403","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T09:26:48Z","timestamp":1747128408000},"page":"3403","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Emerging Advances in the Management of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Narrative Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4225-110X","authenticated-orcid":false,"given":"Shinsuke","family":"Muraoka","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishihori","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsaku","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2484-1360","authenticated-orcid":false,"given":"Ryuta","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"ref_1","unstructured":"GBD 2016 Neurology Collaborators (2019). Global, regional, and national burden of neurological disorders, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol., 18, 459\u2013480."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1474-4422(09)70126-7","article-title":"Changes in case fatality of aneurysmal subarachnoid hemorrhage over time, according to age, sex, and region: A meta-analysis","volume":"8","author":"Nieuwkamp","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","article-title":"Delayed neurological deterioration after subarachnoid hemorrhage","volume":"10","author":"Macdonald","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/WNL.0b013e31827f0fb5","article-title":"Cause-specific mortality of 1-year survivors of subarachnoid hemorrhage","volume":"80","author":"Korja","year":"2013","journal-title":"Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.STR.16.4.562","article-title":"Cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"16","author":"Kassell","year":"1985","journal-title":"Stroke"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3171\/jns.1978.48.2.0173","article-title":"Time course of vasospasm in man","volume":"48","author":"Weir","year":"1978","journal-title":"J. Neurosurg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: Proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e021845","DOI":"10.1161\/JAHA.121.021845","article-title":"Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: A review","volume":"10","author":"Dodd","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/01.STR.30.7.1402","article-title":"Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage","volume":"30","author":"Charpentier","year":"1999","journal-title":"Stroke"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/WNL.55.11.1656","article-title":"Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage","volume":"55","author":"Brilstra","year":"2000","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1161\/01.STR.0000133132.76983.8e","article-title":"Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage","volume":"35","author":"Rabinstein","year":"2004","journal-title":"Stroke"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3171\/jns.1966.25.3.0321","article-title":"Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations","volume":"25","author":"Locksley","year":"1966","journal-title":"J. Neurosurg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/bja\/aes264","article-title":"Delayed cerebral ischaemia after subarachnoid haemorrhage: Looking beyond vaso-spasm","volume":"109","author":"Rowland","year":"2012","journal-title":"Br. J. Anaesth."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1227\/00006123-198001000-00001","article-title":"Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning","volume":"6","author":"Fisher","year":"1980","journal-title":"Neurosurgery"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3171\/jns.1980.53.3.0312","article-title":"Mechanism of cerebral arterial contraction induced by blood constituents","volume":"53","author":"Toda","year":"1980","journal-title":"J. Neurosurg."},{"key":"ref_16","first-page":"H57","article-title":"Mechanisms of contracting action of oxyhemoglobin in isolated monkey and dog cerebral arteries","volume":"258","author":"Toda","year":"1990","journal-title":"Am. J. Physiol."},{"key":"ref_17","first-page":"498","article-title":"Morphometric analysis of monkey cerebral arteries exposed in vivo to whole blood, oxyhemoglobin, methemoglobin, and bilirubin","volume":"28","author":"Macdonaid","year":"1991","journal-title":"Blood Vessel."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.STR.22.8.971","article-title":"A review of hemoglobin and the pathogenesis of cerebral vasospasm","volume":"22","author":"Macdonald","year":"1991","journal-title":"Stroke"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00004647-199804000-00010","article-title":"Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm","volume":"18","author":"Yundt","year":"1998","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.STR.11.6.653","article-title":"Morphometry of brain parenchymal vessels following subarachnoid hemorrhage","volume":"11","author":"Hart","year":"1980","journal-title":"Stroke"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1227\/01.neu.0000306092.07647.6d","article-title":"Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage","volume":"61","author":"Udoetuk","year":"2007","journal-title":"Neurosurgery"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1227\/01.NEU.0000227519.27569.45","article-title":"Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: An autopsy study","volume":"59","author":"Stein","year":"2006","journal-title":"Neurosurgery"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/jnnp.2005.064956","article-title":"Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: Associations with cerebral ischaemic events and outcome","volume":"77","author":"Frijns","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1023\/A:1021985030331","article-title":"Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage","volume":"22","author":"Hirashima","year":"1997","journal-title":"Neurochem. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00006123-199708000-00002","article-title":"Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage","volume":"41","author":"Ikeda","year":"1997","journal-title":"Neurosurgery"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/01.STR.22.7.854","article-title":"Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"22","author":"Ohkuma","year":"1991","journal-title":"Stroke"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3171\/jns.1997.87.2.0207","article-title":"Hemostasis and fibrinolysis activation after subarachnoid hemorrhage","volume":"87","author":"Peltonen","year":"1997","journal-title":"J. Neurosurg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/brain\/awp102","article-title":"Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage","volume":"132","author":"Dreier","year":"2009","journal-title":"Brain"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1093\/brain\/awl297","article-title":"Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations","volume":"129","author":"Dreier","year":"2006","journal-title":"Brain"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/jcbfm.2011.169","article-title":"Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage","volume":"32","author":"Woitzik","year":"2012","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12975-013-0316-8","article-title":"Current management of delayed cerebral ischemia: Update from results of recent clinical trials","volume":"5","author":"Brathwaite","year":"2014","journal-title":"Transl. Stroke Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1161\/STROKEAHA.121.035699","article-title":"Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials","volume":"53","author":"Dayyani","year":"2022","journal-title":"Stroke"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ana.410270118","article-title":"Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage","volume":"27","author":"Hasan","year":"1990","journal-title":"Ann. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ana.410170206","article-title":"Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: Is fluid restriction harmful?","volume":"17","author":"Wijdicks","year":"1985","journal-title":"Ann. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3171\/jns.2003.98.5.0978","article-title":"Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage","volume":"98","author":"Treggiari","year":"2003","journal-title":"J. Neurosurg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13613-016-0128-6","article-title":"Poor outcome is associated with less negative fluid balance in patients with aneurysmal subarachnoid hemorrhage treated with prophylactic vasopressor-induced hypertension","volume":"6","author":"Sakr","year":"2016","journal-title":"Ann. Intensive Care"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12028-011-9573-0","article-title":"The association between fluid balance and outcomes after subarachnoid hemorrhage","volume":"17","author":"Martini","year":"2012","journal-title":"Neurocrit. Care"},{"key":"ref_38","first-page":"e314","article-title":"2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association","volume":"54","author":"Hoh","year":"2023","journal-title":"Stroke"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/STROKEAHA.111.625731","article-title":"Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: A prospective, randomized, controlled trial (LUMAS)","volume":"43","author":"Bhargava","year":"2012","journal-title":"Stroke"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12028-010-9429-z","article-title":"Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis","volume":"14","author":"Kramer","year":"2011","journal-title":"Neurocrit. Care"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamaneurol.2023.1792","article-title":"Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial","volume":"80","author":"Wolf","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_42","first-page":"Cd000277","article-title":"Calcium antagonists for aneurysmal subarachnoid haemorrhage","volume":"2007","author":"Mees","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3171\/jns.1988.68.4.0505","article-title":"Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial","volume":"68","author":"Petruk","year":"1988","journal-title":"J. Neurosurg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3171\/jns.1993.78.4.0537","article-title":"A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study","volume":"78","author":"Haley","year":"1993","journal-title":"J. Neurosurg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3171\/jns.1994.80.5.0788","article-title":"A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study","volume":"80","author":"Haley","year":"1994","journal-title":"J. Neurosurg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10286-004-0186-y","article-title":"Endothelin receptor antagonists and cerebral vasospasm","volume":"14","author":"Zimmermann","year":"2004","journal-title":"Clin. Auton. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1161\/STROKEAHA.109.560243","article-title":"Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: A meta-analysis","volume":"40","author":"Kramer","year":"2009","journal-title":"Stroke"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00701-007-1249-3","article-title":"Effects of the selective endothelin A (ET(A)) receptor antagonist clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage\u2014Preliminary results from a randomized clinical series","volume":"149","author":"Barth","year":"2007","journal-title":"Acta Neurochir."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000475824","article-title":"Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients","volume":"44","author":"Fujimura","year":"2017","journal-title":"Cerebrovasc. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1161\/STROKEAHA.108.519942","article-title":"Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): Randomized, double-blind, placebo-controlled phase 2 dose-finding trial","volume":"39","author":"Macdonald","year":"2008","journal-title":"Stroke"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping: A randomized, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","volume":"10","author":"Macdonald","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/STROKEAHA.111.648980","article-title":"Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling","volume":"43","author":"Macdonald","year":"2012","journal-title":"Stroke"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3171\/jns.2005.103.1.0009","article-title":"Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: Results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study","volume":"103","author":"Vajkoczy","year":"2005","journal-title":"J. Neurosurg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3171\/2022.2.JNS212914","article-title":"Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: Two randomized phase 3 trials in Japanese patients","volume":"137","author":"Endo","year":"2022","journal-title":"J. Neurosurg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10143-023-02104-2","article-title":"Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study","volume":"46","author":"Muraoka","year":"2023","journal-title":"Neurosurg. Rev."},{"key":"ref_56","unstructured":"Muraoka, S., Izumi, T., Nishida, K., Chretien, B., Ishii, K., Takeuchi, I., Nishihori, M., Goto, S., Maesawa, S., and Shimato, S. RECOVER (REtrospective study of Clazosentan and fasudil in subarachnOid hemorrhage: Vasospasm prEvention and patient pRognosis) Study\u2014Comparison of efficacy and safety of clazosentan and fasudil in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study, J. Neurosurg. 2025, in press."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3171\/jns.1992.76.4.0571","article-title":"Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial","volume":"76","author":"Shibuya","year":"1992","journal-title":"J. Neurosurg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2176\/nmc.51.679","article-title":"Efficacy and Safety of Fasudil in Patients With Subarachnoid Hemorrhage: Final Results of a Randomized Trial of Fasudil Versus Nimodipine","volume":"51","author":"Zhao","year":"2011","journal-title":"Neurol. Med.-Chir."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00228-011-1100-x","article-title":"Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage","volume":"68","author":"Liu","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_60","first-page":"Cd006184","article-title":"Antiplatelet therapy for aneurysmal subarachnoid haemorrhage","volume":"2007","author":"Mees","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"134","DOI":"10.7461\/jcen.2020.22.3.134","article-title":"Dual antiplatelet treatment associated with reduced risk of symptomatic vasospasm and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage","volume":"22","author":"Sun","year":"2020","journal-title":"J. Cerebrovasc. Endovasc. Neurosurg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/neuros\/nyy550","article-title":"Post-treatment Antiplatelet Therapy Reduces Risk for Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorrhage","volume":"85","author":"Oppong","year":"2019","journal-title":"Neurosurgery"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000445509","article-title":"Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"42","author":"Matsuda","year":"2016","journal-title":"Cerebrovasc. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3171\/2012.9.JNS12492","article-title":"Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: A multicenter prospective, randomized, open-label blinded end point trial","volume":"118","author":"Senbokuya","year":"2013","journal-title":"J. Neurosurg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000327040","article-title":"Cilostazol improves outcome after subarachnoid hemorrhage: A preliminary report","volume":"32","author":"Suzuki","year":"2011","journal-title":"Cerebrovasc. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clineuro.2004.01.006","article-title":"Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: A double-blind, randomized comparison of enoxaparin versus placebo","volume":"106","author":"Wurm","year":"2004","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3171\/jns.2003.99.6.0953","article-title":"No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled clinical trial","volume":"99","author":"Siironen","year":"2003","journal-title":"J. Neurosurg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3171\/2017.11.JNS17894","article-title":"Continuous infusion of low-dose unfractionated heparin after aneurysmal subarachnoid hemorrhage: A preliminary study of cognitive outcomes","volume":"130","author":"James","year":"2019","journal-title":"J. Neurosurg."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/neuros\/nyaa473","article-title":"Low-Dose Intravenous Heparin Infusion After Aneurysmal Subarachnoid Hemorrhage is Associated With Decreased Risk of Delayed Neurological Deficit and Cerebral Infarction","volume":"88","author":"Kole","year":"2021","journal-title":"Neurosurgery"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3171\/2013.8.JNS1337","article-title":"Low-dose intravenous heparin infusion in patients with aneurysmal subarachnoid hemorrhage: A preliminary assessment","volume":"119","author":"Simard","year":"2013","journal-title":"J. Neurosurg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3171\/2016.5.JNS152900","article-title":"Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis","volume":"127","author":"Shen","year":"2017","journal-title":"J. Neurosurg."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Liu, T., Zhong, S., Zhai, Q., Zhang, X., Jing, H., Li, K., Liu, S., Han, S., Li, L., and Shi, X. (2021). Optimal course of statins for patients with aneurysmal subarachnoid hemorrhage: Is longer treatment better? A meta-analysis of randomized controlled trials. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.757505"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Su, S.H., Xu, W., Hai, J., Wu, Y.F., and Yu, F. (2014). Effects of statins-use for patients with aneurysmal subarachnoid hemorrhage: A meta-analysis of randomized controlled trials. Sci. Rep., 4.","DOI":"10.1038\/srep04573"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12028-009-9267-z","article-title":"Vasospasm and statin therapy: Yet another cautionary tale","volume":"12","author":"Rabinstein","year":"2010","journal-title":"Neurocrit. Care"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"943914","DOI":"10.1155\/2013\/943914","article-title":"The role of magnesium in the management of cerebral vasospasm","volume":"2013","author":"Odom","year":"2013","journal-title":"Neurol. Res. Int."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3340\/jkns.2012.52.2.75","article-title":"Intravenous magnesium infusion for the prevention of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"52","author":"Jeon","year":"2012","journal-title":"J. Korean Neurosurg. Soc."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12028-014-9964-0","article-title":"Prophylactic magnesium sulfate for aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis","volume":"21","author":"Reddy","year":"2014","journal-title":"Neurocrit. Care"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3171\/jns.2005.103.1.0025","article-title":"Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage","volume":"103","author":"Jost","year":"2005","journal-title":"J. Neurosurg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13054-016-1447-6","article-title":"Management of delayed cerebral ischemia after subarachnoid hemorrhage","volume":"20","author":"Francoeur","year":"2016","journal-title":"Crit. Care"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/STROKEAHA.107.502666","article-title":"Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: Results of a phase II multicenter, randomized, clinical trial","volume":"39","author":"Hartman","year":"2008","journal-title":"Stroke"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clineuro.2013.12.012","article-title":"Endovascular management of cerebral vasospasm following aneurysm rupture: Outcomes and predictors in 116 patients","volume":"118","author":"Chalouhi","year":"2014","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00006123-199905000-00022","article-title":"Therapeutic modalities for the management of cerebral vasospasm: Timing of endovascular options","volume":"44","author":"Rosenwasser","year":"1999","journal-title":"Neurosurgery"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.wneu.2015.01.036","article-title":"Results of an International Survey on the Investigation and Endovascular Management of Cerebral Vasospasm and Delayed Cerebral Ischemia","volume":"83","author":"Hollingworth","year":"2015","journal-title":"World Neurosurg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1161\/STROKEAHA.121.034578","article-title":"Phase 1\/2a Trial of ISPASM","volume":"52","author":"Zanaty","year":"2021","journal-title":"Stroke"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"E552","DOI":"10.1093\/neuros\/nyaa170","article-title":"Tirofiban Protocol Protects Against Delayed Cerebral Ischemia: A Case-Series Study","volume":"87","author":"Zanaty","year":"2020","journal-title":"Neurosurgery"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/neuros\/nyx381","article-title":"High-Dose Nadroparin Following Endovascular Aneurysm Treatment Benefits Outcome After Aneurysmal Subarachnoid Hemorrhage","volume":"83","author":"Post","year":"2018","journal-title":"Neurosurgery"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2021.12.FOCUS21663","article-title":"Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: A prospective, randomized, double-blind, placebo-controlled clinical trial","volume":"52","author":"Rios","year":"2022","journal-title":"Neurosurg. Focus"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s12028-021-01398-8","article-title":"A Double-Blind, Randomized, Placebo-Controlled Trial of Soluble Epoxide Hydrolase Inhibition in Patients with Aneurysmal Subarachnoid Hemorrhage","volume":"36","author":"Martini","year":"2022","journal-title":"Neurocrit. Care"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/10\/3403\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:31:55Z","timestamp":1760031115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/10\/3403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":88,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["jcm14103403"],"URL":"https:\/\/doi.org\/10.3390\/jcm14103403","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]}}}